Your Search for 'Pharmacogenomics' returned 310 results - Page 1 of 16

• Pharmacogenomics Partnering Terms and Agreements

  EURO€ 2,148.00USD$ 2,795.00GBP£ 1,808.00AUD$ 2,734.00JPY¥ 275,959.00SEK 18 352,00CHF 2'634.00CAD$ 2,848.00 CurrentPartnering, Apr 2013 , Pages: 416
  Pharmacogenomics Partnering Terms and Agreements The Pharmacogenomic Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the pharmacogenomic ...

• Genetic Diseases and Pharmacogenomics

  EURO€ 692.00USD$ 900.00GBP£ 582.00AUD$ 880.00JPY¥ 88,860.00SEK 5 909,00CHF 848.00CAD$ 917.00 Venture Planning Group (VPG), Feb 2010 , Pages: 75
  Genetic Diseases and Pharmacogenomics The report presents an overview of the clinical significance and market needs for major genetic diseases, reviews the field of pharmacogenomics, and provides ...

• Pharmacogenomics for Clinical Use and in Drug Development

  EURO€ 2,613.00USD$ 3,400.00GBP£ 2,199.00AUD$ 3,325.00JPY¥ 335,692.00SEK 22 324,00CHF 3'205.00CAD$ 3,465.00 TriMark Publications, Jun 2009 , Pages: 244
  Pharmacogenomics for Clinical Use and in Drug Development Pharmacogenomics, the science of individualizing drug therapy based on the genetic makeup of individual patients, offers an unusual ...

• U.S. Pharmacogenomics Markets

  EURO€ 3,421.00USD$ 4,450.00GBP£ 2,878.00AUD$ 4,352.00JPY¥ 439,362.00SEK 29 218,00CHF 4'194.00CAD$ 4,534.00 Frost & Sullivan, Jul 2001
  U.S. Pharmacogenomics Markets Pharmacogenomics Pave the Way for Genetically Tailored Drugs The identification of the human genome's chain sequence is revolutionizing the biotechnology and ...

• Pharmacogenomics in Clinical Therapeutics

  EURO€ 96.00USD$ 125.00GBP£ 81.00AUD$ 122.00JPY¥ 12,359.00SEK 822,00CHF 118.00CAD$ 128.00 John Wiley and Sons Ltd, Feb 2012 , Pages: 256
  Pharmacogenomics in Clinical Therapeutics Pharmacogenomics is the process of analyzing patients' genes to predict the onset of adverse reactions or forecast the effectiveness of therapeutic drugs ...

• How to Get Ahead with Pharmacogenomics

  EURO€ 865.00USD$ 1,125.00GBP£ 728.00AUD$ 1,100.00JPY¥ 111,075.00SEK 7 387,00CHF 1'060.00CAD$ 1,146.00 Decision Resources, Inc, Mar 2008 , Pages: 42
  How to Get Ahead with Pharmacogenomics Introduction Pharmacogenomics (PGx) is an evolutionary—not a revolutionary—process. The “blockbuster” business model is, of course, still relevant to the ...

• European Personalised Medicine and Pharmacogenomics Markets

  EURO€ 5,342.00USD$ 6,950.00GBP£ 4,495.00AUD$ 6,798.00JPY¥ 686,194.00SEK 45 633,00CHF 6'551.00CAD$ 7,082.00 Frost & Sullivan, Oct 2006 , Pages: 71
  European Personalised Medicine and Pharmacogenomics Markets The Frost & Sullivan research service titled European Personalised Medicine and Pharmacogenomics Market provides an overview of the ...

• Impact of Pharmacogenomics on Public Healthcare Policy: Educating Patients, Payors and Healthcare Providers

  EURO€ 2,948.00USD$ 3,835.00GBP£ 2,480.00AUD$ 3,751.00JPY¥ 378,641.00SEK 25 180,00CHF 3'615.00CAD$ 3,908.00 Scripp Business Insights, Mar 2008 , Pages: 171
  Impact of Pharmacogenomics on Public Healthcare Policy: Educating Patients, Payors and Healthcare Providers Immense advances in genetic code decipherment over the last decade have recently led to ...

• Developments in Pharmacogenomics (Technical Insights)

  EURO€ 3,497.00USD$ 4,550.00GBP£ 2,942.00AUD$ 4,450.00JPY¥ 449,235.00SEK 29 875,00CHF 4'289.00CAD$ 4,636.00 Frost & Sullivan, Dec 2005
  Developments in Pharmacogenomics (Technical Insights) Pressure to Optimize Drug Discovery Drives Adoption Considering that the development of a single drug costs an average of $500 million and that ...

• The Role of Pharmacogenomics in Personalized Medicine

  EURO€ 855.00USD$ 1,112.00GBP£ 719.00AUD$ 1,088.00JPY¥ 109,840.00SEK 7 305,00CHF 1'049.00CAD$ 1,134.00 Decision Resources, Inc, Jun 2006 , Pages: 28
  The Role of Pharmacogenomics in Personalized Medicine The pharmaceutical industry is very gradually moving away from the blockbuster model of drug development to a model whereby medicines are ...

• Big Pharma Embraces Pharmacogenomics - But Are We There Yet?

  EURO€ 855.00USD$ 1,112.00GBP£ 719.00AUD$ 1,088.00JPY¥ 109,840.00SEK 7 305,00CHF 1'049.00CAD$ 1,134.00 Decision Resources, Inc, Aug 2006 , Pages: 31
  Big Pharma Embraces Pharmacogenomics - But Are We There Yet? Pharmacogenomics will revolutionize the drug industry by linking the right drug to the right patient. Several companies and regulatory ...

• Pharmacogenomics. Edition No. 2. Drugs and the Pharmaceutical Sciences

  EURO€ 192.00USD$ 250.00GBP£ 162.00AUD$ 244.00JPY¥ 24,678.00SEK 1 641,00CHF 236.00CAD$ 255.00 Informa Healthcare, Sep 2005 , Pages: 696
  Pharmacogenomics. Edition No. 2. Drugs and the Pharmaceutical Sciences Reflecting the shift from genetics to genomics in the pharmaceutical sphere, this Second Edition traces the evolution of the ...

• Pharmacogenomics

  EURO€ 80.00USD$ 104.00GBP£ 67.00AUD$ 101.00JPY¥ 10,222.00SEK 680,00CHF 98.00CAD$ 105.00 John Wiley and Sons Ltd, Apr 2002 , Pages: 599
  Pharmacogenomics This work represents the first comprehensive publication in the innovative field of pharmacogenomics, a field which is set to revolutionize pharmaceutical research. In addition to ...

• Personalized Medicine - Scientific and Commercial Aspects

  EURO€ 3,843.00USD$ 5,000.00GBP£ 3,233.00AUD$ 4,890.00JPY¥ 493,665.00SEK 32 829,00CHF 4'713.00CAD$ 5,095.00 Jain PharmaBiotech, May 2013 , Pages: 854
  design the appropriate treatment for a patient according to his/her genotype. This report describes the latest concepts of development of personalized medicine based on pharmacogenomics, pharmacogenetics ...

• Top 10 Drug Discovery Technologies – Strategic Analysis And Global Forecasts

  EURO€ 3,574.00USD$ 4,650.00GBP£ 3,007.00AUD$ 4,548.00JPY¥ 459,108.00SEK 30 531,00CHF 4'383.00CAD$ 4,738.00 Markets and Markets, Nov 2010 , Pages: 311
  chemotherapy instruments) - Pharmacogenomics - Combinatorial chemistry - Genomics (functional and structural genomics) - Biochips (DNA microarrays, lab on a chip, proteomics microarrays ...

• Pharmacogenomics. Social, Ethical, and Clinical Dimensions

  EURO€ 89.00USD$ 116.00GBP£ 75.00AUD$ 113.00JPY¥ 11,451.00SEK 761,00CHF 109.00CAD$ 118.00 John Wiley and Sons Ltd, Jan 2003 , Pages: 384
  Pharmacogenomics. Social, Ethical, and Clinical Dimensions Through analyses of the complex underlying issues, this interdisciplinary volume frames the agenda for dealing with genetic variation and ...

• Therapeutic Drug Monitoring

  EURO€ 122.00USD$ 159.00GBP£ 103.00AUD$ 155.00JPY¥ 15,671.00SEK 1 042,00CHF 150.00CAD$ 162.00 Elsevier Science and Technology, Aug 2012 , Pages: 468
  Therapeutic Drug Monitoring Therapeutic Drug Monitoring: Newer Drugs and Biomarkers features timely topics such as the monitoring of classical and newer drugs, pharmacogenomics and the application of ...

• Personalized Medicine - A Strategic Analysis of Industry Trends, Technologies, Participants and Environment

  EURO€ 2,790.00USD$ 3,630.00GBP£ 2,347.00AUD$ 3,550.00JPY¥ 358,372.00SEK 23 832,00CHF 3'421.00CAD$ 3,699.00 Kelly Scientific Publications, May 2013 , Pages: 161
  , UK, EU) - By Segment (Targeted therapeutics, Esoteric tests, Esoteric lab services) - By Sub-market (Companion diagnostics & therapeutic, nutrition & wellness, medical technology, pharmacogenomics ...

• Personalized Medicine

  EURO€ 1,537.00USD$ 1,999.00GBP£ 1,293.00AUD$ 1,955.00JPY¥ 197,367.00SEK 13 125,00CHF 1'884.00CAD$ 2,037.00 TriMark Publications, Aug 2007 , Pages: 87
  Personalized Medicine Personalized medicine and pharmacogenomics are inextricably linked. Pharmacogenomics is the use of genetic variations (such as SNPs, gene expression variability, or other ...

• Molecular Diagnostics - Global Strategic Business Report

  EURO€ 4,381.00USD$ 4,950.00GBP£ 2,920.00AUD$ 6,845.00JPY¥ 593,598.00SEK 38 940,00CHF 6'519.00CAD$ 6,349.00 Global Industry Analysts, Inc, Nov 2012 , Pages: 572
  Testing, Pharmacogenomics, and Cancer Screening. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are ...